EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Modeling the impact of COVID‐19 nonpharmaceutical interventions on respiratory syncytial virus transmission in South Africa

Samantha J Bents iD, Cécile Viboud, Bryan T Grenfell, Alexandra B Hogan, Stefano Tempia iD, Anne von Gottberg, Jocelyn Moyes, Sibongile Walaza iD, Chelsea Hansen, Cheryl Cohen iD, Rachel E Baker

Influenza and Other Respiratory Viruses · 2023-12 · 17 (12)

DOI: 10.1111/irv.13229 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Influenza and Other Respiratory Viruses, online erschienen am 10.12.2023. Verfasst von Samantha J Bents und 10 weiteren Autor:innen. Beteiligte Einrichtung: Fogarty International Center, National Institutes of Health Bethesda Maryland USA. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, COVID-19, Respiratory Syncytial Virus, Human. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, NCIRD CDC HHS, Foreign, Commonwealth and Development Office.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The South African government employed various nonpharmaceutical interventions (NPIs) to reduce the spread of SARS‐CoV‐2. Surveillance data from South Africa indicates reduced circulation of respiratory syncytial virus (RSV) throughout the 2020–2021 seasons. Here, we use a mechanistic transmission model to project the rebound of RSV in the two subsequent seasons.

Methods

We fit an age‐structured epidemiological model to hospitalization data from national RSV surveillance in South Africa, allowing for time‐varying reduction in RSV transmission during periods of COVID‐19 circulation. We apply the model to project the rebound of RSV in the 2022 and 2023 seasons.

Results

We projected an early and intense outbreak of RSV in April 2022, with an age shift to older infants (6–23 months old) experiencing a larger portion of severe disease burden than typical. In March 2022, government alerts were issued to prepare the hospital system for this potentially intense outbreak. We then assess the 2022 predictions and project the 2023 season. Model predictions for 2023 indicate that RSV activity has not fully returned to normal, with a projected early and moderately intense wave. We estimate that NPIs reduced RSV transmission between 15% and 50% during periods of COVID‐19 circulation.

Conclusions

A wide range of NPIs impacted the dynamics of the RSV outbreaks throughout 2020–2023 in regard to timing, magnitude, and age structure, with important implications in a low‐ and middle‐income countries (LMICs) setting where RSV interventions remain limited. More efforts should focus on adapting RSV models to LMIC data to project the impact of upcoming medical interventions for this disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory Syncytial Virus InfectionsCOVID-19Respiratory Syncytial Virus, HumanInfantHumansChild, PreschoolSouth AfricaSARS-CoV-2Seasons

Stichwörter der Autor:innen

COVID‐19epidemiological modelslow‐ and middle‐income countriesrespiratory syncytial virus

Autor:innen und Institutionen

  • Fogarty International Center, National Institutes of Health Bethesda Maryland USA.
  • Department of Ecology and Evolutionary Biology Princeton University Princeton New Jersey USA.
  • School of Population Health University of New South Wales Sydney New South Wales Australia.
  • Centre for Respiratory Diseases and Meningitis National Institute for Communicable Diseases of the National Health Laboratory Service Johannesburg South Africa.
  • School of Public Health, Faculty of Health Sciences University of Witwatersrand Johannesburg South Africa.
  • School of Pathology, Faculty of Health Sciences University of Witwatersrand Johannesburg South Africa.

ORCID-Profile: Samantha J Bents, Stefano Tempia, Sibongile Walaza, Cheryl Cohen

Förderung

  • Wellcome Trust
  • NCIRD CDC HHS
  • Foreign, Commonwealth and Development Office

Zitieren

APA

Bents, S. J., Viboud, C., Grenfell, B. T., Hogan, A. B., Tempia, S., von Gottberg, A., Moyes, J., Walaza, S., Hansen, C., Cohen, C., & Baker, R. E. (2023). Modeling the impact of COVID‐19 nonpharmaceutical interventions on respiratory syncytial virus transmission in South Africa. Influenza and Other Respiratory Viruses, 17(12). https://doi.org/10.1111/irv.13229

Vancouver

Bents SJ, Viboud C, Grenfell BT, Hogan AB, Tempia S, von Gottberg A, et al. Modeling the impact of COVID‐19 nonpharmaceutical interventions on respiratory syncytial virus transmission in South Africa. Influenza and Other Respiratory Viruses. 2023;17(12). doi:10.1111/irv.13229

BibTeX
@article{Bents2023,
  author = {Bents, Samantha J and Viboud, Cécile and Grenfell, Bryan T and Hogan, Alexandra B and Tempia, Stefano and von Gottberg, Anne and Moyes, Jocelyn and Walaza, Sibongile and Hansen, Chelsea and Cohen, Cheryl and Baker, Rachel E},
  title = {Modeling the impact of COVID‐19 nonpharmaceutical interventions on respiratory syncytial virus transmission in South Africa},
  journal = {Influenza and Other Respiratory Viruses},
  year = {2023},
  volume = {17},
  number = {12},
  doi = {10.1111/irv.13229}
}
Kostenlos starten →